title: The potential impact of helminth infection on trials of novel tuberculosis vaccines.
authors.forename: Mark
authors.initials: M
authors.lastname: Hatherill
authors.forename: Vera
authors.initials: V
authors.lastname: Adams
authors.forename: Jane
authors.initials: J
authors.lastname: Hughes
authors.forename: Marwou
authors.initials: M
authors.lastname: De Kock
authors.forename: Wendy
authors.initials: W
authors.lastname: Mavakla
authors.forename: Bernadette
authors.initials: B
authors.lastname: Pienaar
authors.forename: Hassan
authors.initials: H
authors.lastname: Mahomed
authors.forename: Gregory
authors.initials: G
authors.lastname: Hussey
authors.forename: Willem A
authors.initials: WA
authors.lastname: Hanekom
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D002986:Clinical Trials as Topic; D005260:Female; D006373:Helminthiasis / Q000276:immunology*; D006376:Helminths / Q000276:immunology*; D006801:Humans; D011247:Pregnancy; D032581:Tuberculosis Vaccines / Q000276:immunology*; D055815:Young Adult
chemical_list: D032581:Tuberculosis Vaccines